BioMarin Pharmaceutical, Inc. (BMRN)

64.72 +0.64 (+1.00%) USD  |  NASDAQ  |  Feb 23, 11:39
More

BioMarin Pharmaceutical EBITDA Estimates for Current Quarter

EBITDA Estimates for Current Quarter Chart

View EBITDA Estimates for Current Quarter for BMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Estimates for Current Quarter Range, Past 5 Years

View EBITDA Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Estimates for Current Quarter Benchmarks

View EBITDA Estimates for Current Quarter Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Merck & Co., Inc. Upgrade
AbbVie, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade